Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Communications
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. nature communications
  3. articles
  4. article
Dissecting PGE2-driven inhibition of T cell activation using single-cell multi-omic and inflammatory bowel disease genetic association analysis
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 07 April 2026

Dissecting PGE2-driven inhibition of T cell activation using single-cell multi-omic and inflammatory bowel disease genetic association analysis

  • Zhongli Xu  ORCID: orcid.org/0000-0001-6843-62121,2 na1,
  • Shiyue Tao1,3 na1,
  • Site Feng  ORCID: orcid.org/0000-0002-3946-40432,4,
  • Xiangyu Ye1,
  • Ting Wang1,
  • Haoran Hu  ORCID: orcid.org/0000-0003-3619-28521,3,
  • Elisa Heidrich-O’Hare4,
  • Wei Chen  ORCID: orcid.org/0000-0001-7196-87031,3,5 &
  • …
  • Richard H. Duerr  ORCID: orcid.org/0000-0001-6586-39054,5,6 

Nature Communications , Article number:  (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Autoimmunity
  • Epigenomics
  • Gene expression
  • Inflammatory bowel disease
  • T cells

Abstract

Genetic and immunologic studies implicate the interleukin (IL)-23/T helper (Th)17 pathway in inflammatory bowel disease (IBD). IL-23 and IL-1β drive human Th17 differentiation, while prostaglandin E2 (PGE2) and transforming growth factor-β (TGF-β) further modulate Th17 development and plasticity. However, how these inflammatory mediators influence human T cell regulatory programs remains incompletely understood. We used single-cell multi-omics to profile 171,829 peripheral blood T cells from 25 healthy donors in 64 samples exposed to activation stimuli, IL-1β and IL-23 alone or in combination with PGE2, TGF-β, or both. PGE2 broadly suppressed T cell activation, except in Th17 and T follicular helper cells, and markedly altered chromatin accessibility and gene expression, particularly in Th17, Th1, and regulatory T cells, where IBD-associated SNPs were enriched in open chromatin and connected to cell type-specific cis-regulatory elements. Our study demonstrates the utility of single-cell multi-omics for defining stimulus-specific effects on T cells and prioritizing disease-associated genes.

Data availability

The DOGMA-seq data generated in this study are available in the database of Genotypes and Phenotypes (dbGaP; accession number: phs004468.v1.p1; https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs004468.v1.p1) in accordance with the University of Pittsburgh Institutional Review Board consent, which stipulates that individual-level genomic data may be placed in controlled-access databases. Access to these data requires submission of a data access request to dbGaP and approval by the corresponding Data Access Committee. Approved users must agree to the dbGaP data use certification and comply with all data use restrictions. Requests are typically reviewed within 2–4 weeks of submission. Bulk ATAC-seq and bulk RNA-seq data are available by contacting the corresponding author and executing a data use agreement in compliance with institutional and ethical regulations. The University of Pittsburgh Institutional Review Board determined that the bulk ATAC-seq and bulk RNA-seq data cannot be deposited into public repositories because human study participants who provided samples for bulk ATAC-seq and bulk RNA-seq did not provide explicit informed consent for deposition of genomic sequencing data into public repositories. Requests for access will be reviewed within 2–4 weeks. The reused dataset EGAD00001005291 can be found at the European Phenome-Genome Archive (https://ega-archive.org/studies/EGAS00001003823). All other data are available in the article and its Supplementary files or from the corresponding author upon request. Source data are provided with this paper.

Code availability

Scripts to reproduce the analyses are available on GitHub (https://github.com/CHPGenetics/DOGMA_PBMC_T) and archived on Zenodo140.

References

  1. Molodecky, N. A. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46–54e42 (2012).

    Google Scholar 

  2. Ananthakrishnan, A. N. Epidemiology and risk factors for IBD. Nat. Rev. Gastroenterol. Hepatol. 12, 205–217 (2015).

    Google Scholar 

  3. Mak, W. Y., Zhao, M., Ng, S. C. & Burisch, J. The epidemiology of inflammatory bowel disease: east meets west. J. Gastroenterol. Hepatol. 35, 380–389 (2020).

    Google Scholar 

  4. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).

    Google Scholar 

  5. Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015).

    Google Scholar 

  6. de Lange, K. M. et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat. Genet. 49, 256–261 (2017).

    Google Scholar 

  7. Luo, Y. et al. Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7. Nat. Genet. 49, 186–192 (2017).

    Google Scholar 

  8. Tesmer, L. A., Lundy, S. K., Sarkar, S. & Fox, D. A. Th17 cells in human disease. Immunol. Rev. 223, 87–113 (2008).

    Google Scholar 

  9. Croxford, A. L., Mair, F. & Becher, B. IL-23: one cytokine in control of autoimmunity. Eur. J. Immunol. 42, 2263–2273 (2012).

    Google Scholar 

  10. Geremia, A. & Jewell, D. P. The IL-23/IL-17 pathway in inflammatory bowel disease. Expert Rev. Gastroenterol. Hepatol. 6, 223–237 (2012).

    Google Scholar 

  11. Monteleone, I., Pallone, F. & Monteleone, G. Th17-related cytokines: new players in the control of chronic intestinal inflammation. BMC Med. 9, 122 (2011).

    Google Scholar 

  12. Monteleone, I., Sarra, M., Pallone, F. & Monteleone, G. Th17-related cytokines in inflammatory bowel diseases: friends or foes? Curr. Mol. Med. 12, 592–597 (2012).

    Google Scholar 

  13. Weaver, C. T., Elson, C. O., Fouser, L. A. & Kolls, J. K. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 8, 477–512 (2013).

    Google Scholar 

  14. Troncone, E., Marafini, I., Pallone, F. & Monteleone, G. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad. Int. Rev. Immunol. 32, 526–533 (2013).

    Google Scholar 

  15. Bianchi, E. & Rogge, L. The IL-23/IL-17 pathway in human chronic inflammatory diseases-new insight from genetics and targeted therapies. Genes Immun. 20, 415–425 (2019).

    Google Scholar 

  16. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942–949 (2007).

    Google Scholar 

  17. Annunziato, F. et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204, 1849–1861 (2007).

    Google Scholar 

  18. Wilson, N. J. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950–957 (2007).

    Google Scholar 

  19. Boniface, K., Blom, B., Liu, Y. J. & de Waal Malefyt, R. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol. Rev. 226, 132–146 (2008).

    Google Scholar 

  20. Chizzolini, C. et al. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 112, 3696–3703 (2008).

    Google Scholar 

  21. Boniface, K. et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 206, 535–548 (2009).

    Google Scholar 

  22. Lee, Y. K. et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92–107 (2009).

    Google Scholar 

  23. Barrie, A. et al. Prostaglandin E2 and IL-23 plus IL-1beta differentially regulate the Th1/Th17 immune response of human CD161(+) CD4(+) memory T cells. Clin. Transl. Sci. 4, 268–273 (2011).

    Google Scholar 

  24. Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255–263 (2011).

    Google Scholar 

  25. Sreeramkumar, V., Fresno, M. & Cuesta, N. Prostaglandin E2 and T cells: friends or foes? Immunol. Cell Biol. 90, 579–586 (2012).

    Google Scholar 

  26. Garrido-Mesa, N., Algieri, F., Rodriguez Nogales, A. & Galvez, J. Functional plasticity of Th17 cells: implications in gastrointestinal tract function. Int. Rev. Immunol. 32, 493–510 (2013).

    Google Scholar 

  27. Kleinewietfeld, M. & Hafler, D. A. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin. Immunol. 25, 305–312 (2013).

    Google Scholar 

  28. Muranski, P. & Restifo, N. P. Essentials of Th17 cell commitment and plasticity. Blood 121, 2402–2414 (2013).

    Google Scholar 

  29. Sundrud, M. S. & Trivigno, C. Identity crisis of Th17 cells: many forms, many functions, many questions. Semin. Immunol. 25, 263–272 (2013).

    Google Scholar 

  30. Zuniga, L. A., Jain, R., Haines, C. & Cua, D. J. Th17 cell development: from the cradle to the grave. Immunol. Rev. 252, 78–88 (2013).

    Google Scholar 

  31. Travis, M. A. & Sheppard, D. TGF-beta activation and function in immunity. Annu. Rev. Immunol. 32, 51–82 (2014).

    Google Scholar 

  32. Harbour, S. N., Maynard, C. L., Zindl, C. L., Schoeb, T. R. & Weaver, C. T. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc. Natl. Acad. Sci. USA 112, 7061–7066 (2015).

    Google Scholar 

  33. Ueno, A., Ghosh, A., Hung, D., Li, J. & Jijon, H. Th17 plasticity and its changes associated with inflammatory bowel disease. World J. Gastroenterol. 21, 12283–12295 (2015).

    Google Scholar 

  34. Diller, M. L., Kudchadkar, R. R., Delman, K. A., Lawson, D. H. & Ford, M. L. Balancing inflammation: the Link between Th17 and regulatory T cells. Mediat. Inflamm. 2016, 6309219 (2016).

    Google Scholar 

  35. Revu, S. et al. IL-23 and IL-1beta drive human Th17 cell differentiation and metabolic reprogramming in absence of CD28 costimulation. Cell Rep. 22, 2642–2653 (2018).

    Google Scholar 

  36. Schnell, A. et al. Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. Cell 184, 6281–6298 e23 (2021).

    Google Scholar 

  37. Buckner, J. H. & Harrison, O. J. Th17 cells: from gut homeostasis to CNS pathogenesis. Trends Immunol. 43, 167–169 (2022).

    Google Scholar 

  38. Pawlak, M. et al. Induction of a colitogenic phenotype in Th1-like cells depends on interleukin-23 receptor signaling. Immunity 55, 1663–1679.e6 (2022).

    Google Scholar 

  39. Laudisi, F., Stolfi, C., Monteleone, I. & Monteleone, G. TGF-beta1 signaling and Smad7 control T-cell responses in health and immune-mediated disorders. Eur. J. Immunol. 53, e2350460 (2023).

    Google Scholar 

  40. Mahida, Y. R., Wu, K. & Jewell, D. P. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn’s disease. Gut 30, 835–838 (1989).

    Google Scholar 

  41. Wardle, T. D., Hall, L. & Turnberg, L. A. Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 33, 1644–1651 (1992).

    Google Scholar 

  42. McCabe, R. P., Secrist, H., Botney, M., Egan, M. & Peters, M. G. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin. Immunol. Immunopathol. 66, 52–58 (1993).

    Google Scholar 

  43. Babyatsky, M. W., Rossiter, G. & Podolsky, D. K. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 110, 975–984 (1996).

    Google Scholar 

  44. Fuss, I. J. et al. Both IL-12p70 and IL-23 are synthesized during active Crohn’s disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 12, 9–15 (2006).

    Google Scholar 

  45. Neurath, M. F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14, 329–342 (2014).

    Google Scholar 

  46. Ernst, J. et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43–49 (2011).

    Google Scholar 

  47. Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190–1195 (2012).

    Google Scholar 

  48. Trynka, G. et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124–130 (2013).

    Google Scholar 

  49. Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934–947 (2013).

    Google Scholar 

  50. Rivera, C. M. & Ren, B. Mapping human epigenomes. Cell 155, 39–55 (2013).

    Google Scholar 

  51. Farh, K. K. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337–343 (2015).

    Google Scholar 

  52. Mells, G. F. & Hirschfield, G. M. Making the most of new genetic risk factors—genetic and epigenetic fine mapping of causal autoimmune disease variants. Clin. Res. Hepatol. Gastroenterol. 39, 408–411 (2015).

    Google Scholar 

  53. Wang, K. C. & Chang, H. Y. Epigenomics: technologies and applications. Circ. Res. 122, 1191–1199 (2018).

    Google Scholar 

  54. Mimitou, E. P. et al. Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells. Nat. Biotechnol. 39, 1246–1258 (2021).

    Google Scholar 

  55. Swanson, E. et al. Simultaneous trimodal single-cell measurement of transcripts, epitopes, and chromatin accessibility using TEA-seq. Elife 10, e63632 (2021).

  56. Xu, Z., Heidrich-O’Hare, E., Chen, W. & Duerr, R. H. Comprehensive benchmarking of CITE-seq versus DOGMA-seq single cell multimodal omics. Genome Biol. 23, 135 (2022).

    Google Scholar 

  57. Hosokawa, H. & Rothenberg, E. V. How transcription factors drive choice of the T cell fate. Nat. Rev. Immunol. 21, 162–176 (2021).

    Google Scholar 

  58. Soskic, B. et al. Immune disease risk variants regulate gene expression dynamics during CD4(+) T cell activation. Nat. Genet. 54, 817–826 (2022).

    Google Scholar 

  59. Benito, J. M., Lopez, M., Lozano, S., Gonzalez-Lahoz, J. & Soriano, V. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy. J. Infect. Dis. 198, 1466–1473 (2008).

    Google Scholar 

  60. Reddy, M., Eirikis, E., Davis, C., Davis, H. M. & Prabhakar, U. Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function. J. Immunol. Methods 293, 127–142 (2004).

    Google Scholar 

  61. Cano-Gamez, E. et al. Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4(+) T cells to cytokines. Nat. Commun. 11, 1801 (2020).

    Google Scholar 

  62. Epstein, P. M. Different phosphodiesterases (PDEs) regulate distinct phosphoproteomes during cAMP signaling. Proc. Natl. Acad. Sci. USA 114, 7741–7743 (2017).

    Google Scholar 

  63. Bielenberg, M., Kurelic, R., Frantz, S. & Nikolaev, V. O. A mini-review: phosphodiesterases in charge to balance intracellular cAMP during T-cell activation. Front. Immunol. 15, 1365484 (2024).

    Google Scholar 

  64. Tavares, L. P. et al. Blame the signaling: role of cAMP for the resolution of inflammation. Pharm. Res. 159, 105030 (2020).

    Google Scholar 

  65. Kamthong, P. J. & Wu, M. Inhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expression. Biochem. J. 356, 525–530 (2001).

    Google Scholar 

  66. Gerlo, S. et al. Cyclic AMP: a selective modulator of NF-kappaB action. Cell. Mol. Life Sci. 68, 3823–3841 (2011).

    Google Scholar 

  67. Lee, J. et al. T cell–intrinsic prostaglandin E2-EP2/EP4 signaling is critical in pathogenic TH17 cell-driven inflammation. J. Allergy Clin. Immunol. 143, 631–643 (2019).

    Google Scholar 

  68. Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960–976 (2017).

    Google Scholar 

  69. Wek, R. C. Role of eIF2alpha kinases in translational control and adaptation to cellular stress. Cold Spring Harb. Perspect. Biol. 10, a032870 (2018).

    Google Scholar 

  70. Huang, H. et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature 547, 173–178 (2017).

    Google Scholar 

  71. Soskic, B. et al. Chromatin activity at GWAS loci identifies T cell states driving complex immune diseases. Nat. Genet. 51, 1486–1493 (2019).

    Google Scholar 

  72. Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307–317 (2011).

    Google Scholar 

  73. Haga, K. et al. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis. J. Gastroenterol. Hepatol. 31, 965–972 (2016).

    Google Scholar 

  74. Jaeger, N. et al. Single-cell analyses of Crohn’s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions. Nat. Commun. 12, 1921 (2021).

    Google Scholar 

  75. Gazal, S. et al. Linkage disequilibrium-dependent architecture of human complex traits shows action of negative selection. Nat. Genet. 49, 1421–1427 (2017).

    Google Scholar 

  76. Finucane, H. K. et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 50, 621–629 (2018).

    Google Scholar 

  77. Huang, J. L., Tan, W. T. & Liu, H. Prostaglandins and inflammatory bowel disease: from mechanism to clinic. Inflamm. Bowel Dis. 31, 2907–2916 (2025).

  78. Long, M. D. et al. Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease. J. Clin. Gastroenterol. 50, 152–156 (2016).

    Google Scholar 

  79. Preissl, S., Gaulton, K. J. & Ren, B. Characterizing cis-regulatory elements using single-cell epigenomics. Nat. Rev. Genet. 24, 21–43 (2023).

    Google Scholar 

  80. Granja, J. M. et al. ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat. Genet. 53, 403–411 (2021).

    Google Scholar 

  81. Mitra, S. et al. Single-cell multi-ome regression models identify functional and disease-associated enhancers and enable chromatin potential analysis. Nat. Genet. 56, 627–636 (2024).

    Google Scholar 

  82. Evans, D. M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43, 761–767 (2011).

    Google Scholar 

  83. Yazar, S. et al. Single-cell eQTL mapping identifies cell type-specific genetic control of autoimmune disease. Science 376, eabf3041 (2022).

    Google Scholar 

  84. Vosa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet 53, 1300–1310 (2021).

    Google Scholar 

  85. Carithers, L. J. et al. A novel approach to high-quality postmortem tissue procurement: the GTEx project. Biopreserv. Biobank. 13, 311–319 (2015).

    Google Scholar 

  86. Drobin, K. et al. Targeted analysis of serum proteins encoded at known inflammatory bowel disease risk loci. Inflamm. Bowel Dis. 25, 306–316 (2019).

    Google Scholar 

  87. Kaser, A., Zeissig, S. & Blumberg, R. S. Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future? Dig. Dis. 28, 395–405 (2010).

    Google Scholar 

  88. Rao, S. S. et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665–1680 (2014).

    Google Scholar 

  89. Wang, Y. et al. The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions. Genome Biol. 19, 151 (2018).

    Google Scholar 

  90. Yasuda, K. et al. Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation. Nat. Commun. 10, 549 (2019).

    Google Scholar 

  91. Ntunzwenimana, J. C. et al. Functional screen of inflammatory bowel disease genes reveals key epithelial functions. Genome Med. 13, 181 (2021).

    Google Scholar 

  92. Ruiz, F. et al. A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease. Br. J. Pharm. 178, 3157–3175 (2021).

    Google Scholar 

  93. Baars, M. J. D. et al. Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity. Eur. J. Immunol. 51, 471–482 (2021).

    Google Scholar 

  94. Chen, M. H. et al. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell 182, 1198–1213 e14 (2020).

    Google Scholar 

  95. Di Meglio, P. et al. Targeting CD8(+) T cells prevents psoriasis development. J. Allergy Clin. Immunol. 138, 274–276 e6 (2016).

    Google Scholar 

  96. Cavers, A. et al. Behcet’s disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity. Ann. Rheum. Dis. 81, 1603–1611 (2022).

    Google Scholar 

  97. Ali, N. et al. Regulatory T cells in skin facilitate epithelial stem cell differentiation. Cell 169, 1119–1129 e11 (2017).

    Google Scholar 

  98. Castela, E. et al. Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata. JAMA Dermatol. 150, 748–751 (2014).

    Google Scholar 

  99. Yang, X. et al. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 612, 771–777 (2022).

    Google Scholar 

  100. Chen, P. M. & Tsokos, G. C. The role of CD8+ T-cell systemic lupus erythematosus pathogenesis: an update. Curr. Opin. Rheumatol. 33, 586–591 (2021).

    Google Scholar 

  101. Wolk, K. et al. IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci. Transl. Med. 5, 204ra129 (2013).

    Google Scholar 

  102. Harden, J. L., Krueger, J. G. & Bowcock, A. M. The immunogenetics of psoriasis: a comprehensive review. J. Autoimmun. 64, 66–73 (2015).

    Google Scholar 

  103. Zhang, K. et al. A single-cell atlas of chromatin accessibility in the human genome. Cell 184, 5985–6001.e19 (2021).

    Google Scholar 

  104. Sheibanie, A. F. et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23->IL-17 axis. J. Immunol. 178, 8138–8147 (2007).

    Google Scholar 

  105. Freimer, J. W. et al. Systematic discovery and perturbation of regulatory genes in human T cells reveals the architecture of immune networks. Nat. Genet. 54, 1133–1144 (2022).

    Google Scholar 

  106. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213–1218 (2013).

    Google Scholar 

  107. Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21 29 1–21 29 9 (2015).

    Google Scholar 

  108. Melsted, P. et al. Modular, efficient and constant-memory single-cell RNA-seq preprocessing. Nat. Biotechnol. 39, 813–818 (2021).

    Google Scholar 

  109. Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 e29 (2021).

    Google Scholar 

  110. Stuart, T., Srivastava, A., Madad, S., Lareau, C. A. & Satija, R. Single-cell chromatin state analysis with Signac. Nat. Methods 18, 1333–1341 (2021).

    Google Scholar 

  111. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).

    Google Scholar 

  112. Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).

    Google Scholar 

  113. Ahlmann-Eltze, C. & Huber, W. glmGamPoi: fitting Gamma-Poisson generalized linear models on single cell count data. Bioinformatics 36, 5701–5702 (2021).

    Google Scholar 

  114. Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).

    Google Scholar 

  115. McInnes, L., Healy, J. & Melville, J. UMAP: uniform manifold approximation and projection for dimension reduction. arXiv:1802.03426 (2018).

  116. Cusanovich, D. A. et al. Multiplex single cell profiling of chromatin accessibility by combinatorial cellular indexing. Science 348, 910–914 (2015).

    Google Scholar 

  117. Schep, A. N., Wu, B., Buenrostro, J. D. & Greenleaf, W. J. chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat. Methods 14, 975–978 (2017).

    Google Scholar 

  118. Zappia, L. & Oshlack, A. Clustering trees: a visualization for evaluating clusterings at multiple resolutions. Gigascience 7, giy083 (2018).

    Google Scholar 

  119. Squair, J. W. et al. Confronting false discoveries in single-cell differential expression. Nat. Commun. 12, 5692 (2021).

    Google Scholar 

  120. Kramer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523–530 (2014).

    Google Scholar 

  121. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).

    Google Scholar 

  122. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).

    Google Scholar 

  123. Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323 (2011).

    Google Scholar 

  124. Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276–278 (2020).

    Google Scholar 

  125. Dou, J. et al. Single-nucleotide variant calling in single-cell sequencing data with Monopogen. Nat. Biotechnol. 42, 803–812 (2024).

    Google Scholar 

  126. Siva, N. 1000 Genomes project. Nat. Biotechnol. 26, 256 (2008).

    Google Scholar 

  127. Delaneau, O., Zagury, J. F., Robinson, M. R., Marchini, J. L. & Dermitzakis, E. T. Accurate, scalable and integrative haplotype estimation. Nat. Commun. 10, 5436 (2019).

    Google Scholar 

  128. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).

    Google Scholar 

  129. DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491–498 (2011).

    Google Scholar 

  130. Zhang, S. et al. Allele-specific open chromatin in human iPSC neurons elucidates functional disease variants. Science 369, 561–565 (2020).

    Google Scholar 

  131. Zhang, B. et al. Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19. Cell Genom. 3, 100232 (2023).

    Google Scholar 

  132. Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).

    Google Scholar 

  133. Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).

    Google Scholar 

  134. The 1000 Genomes Project Consortium et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).

    Google Scholar 

  135. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).

    Google Scholar 

  136. Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353–1358 (2012).

    Google Scholar 

  137. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576–589 (2010).

    Google Scholar 

  138. Gene Ontology Consortium. The Gene Ontology resource: enriching a GOld mine. Nucleic Acids Res. 49, D325–D334 (2021).

    Google Scholar 

  139. Gene Ontology Consortium et al. The Gene Ontology knowledgebase in 2023. Genetics 224, (2023).

  140. Xu, Z. & Tao, S. Dissecting PGE2-driven Inhibition of T Cell Activation Using Single-cell Multi-omic And Inflammatory Bowel Disease Genetic Association Analysis. Github release DOGMA_PBMC_T v1.0.0. https://doi.org/10.5281/zenodo.18248881 (2026).

Download references

Acknowledgements

This research was supported by National Institute of Diabetes and Digestive and Kidney Diseases grants U01DK062420 and R01DK138458, and the University of Pittsburgh Center for Research Computing and Data, RRID:SCR_022735, through the resources provided. Specifically, this work used the HTC cluster, which is supported by NIH award number S10OD028483.

Author information

Author notes
  1. These authors contributed equally: Zhongli Xu, Shiyue Tao.

Authors and Affiliations

  1. Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA

    Zhongli Xu, Shiyue Tao, Xiangyu Ye, Ting Wang, Haoran Hu & Wei Chen

  2. School of Medicine, Tsinghua University, Beijing, China

    Zhongli Xu & Site Feng

  3. Department of Biostatistics and Health Data Science, University of Pittsburgh, Pittsburgh, PA, USA

    Shiyue Tao, Haoran Hu & Wei Chen

  4. Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA

    Site Feng, Elisa Heidrich-O’Hare & Richard H. Duerr

  5. Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA, USA

    Wei Chen & Richard H. Duerr

  6. Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA

    Richard H. Duerr

Authors
  1. Zhongli Xu
    View author publications

    Search author on:PubMed Google Scholar

  2. Shiyue Tao
    View author publications

    Search author on:PubMed Google Scholar

  3. Site Feng
    View author publications

    Search author on:PubMed Google Scholar

  4. Xiangyu Ye
    View author publications

    Search author on:PubMed Google Scholar

  5. Ting Wang
    View author publications

    Search author on:PubMed Google Scholar

  6. Haoran Hu
    View author publications

    Search author on:PubMed Google Scholar

  7. Elisa Heidrich-O’Hare
    View author publications

    Search author on:PubMed Google Scholar

  8. Wei Chen
    View author publications

    Search author on:PubMed Google Scholar

  9. Richard H. Duerr
    View author publications

    Search author on:PubMed Google Scholar

Contributions

Z.X., W.C., and R.D. conceived the project and designed the experiments. S.F. and E.H. performed experiments. Z.X., S.T., S.F., X.Y., T.W., and H.H. performed data analysis. Z.X., S.T., S.F., T.W., E.H., W.C., and R.D. wrote the manuscript. W.C. and R.D. supervised the work.

Corresponding authors

Correspondence to Wei Chen or Richard H. Duerr.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Communications thanks Vanessa Mitsialis and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information (download PDF )

Description of Additional Supplementary Files (download PDF )

Supplementary Data 1–20 (download ZIP )

Reporting Summary (download PDF )

Transparent Peer Review file (download PDF )

Source data

Source Data (download ZIP )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, Z., Tao, S., Feng, S. et al. Dissecting PGE2-driven inhibition of T cell activation using single-cell multi-omic and inflammatory bowel disease genetic association analysis. Nat Commun (2026). https://doi.org/10.1038/s41467-026-71383-2

Download citation

  • Received: 17 March 2025

  • Accepted: 23 March 2026

  • Published: 07 April 2026

  • DOI: https://doi.org/10.1038/s41467-026-71383-2

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Editors
  • Journal Information
  • Open Access Fees and Funding
  • Calls for Papers
  • Editorial Values Statement
  • Journal Metrics
  • Editors' Highlights
  • Contact
  • Editorial policies
  • Top Articles

Publish with us

  • For authors
  • For Reviewers
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Communications (Nat Commun)

ISSN 2041-1723 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing